Navigation Links
NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
Date:6/13/2008

acy end points, like the Modified Osteoarthritis Research Society International (OARSI) responder rate, a visual analog scale (VAS) of pain intensity during rest or walking and investigators' overall rating of disease status, treatment and response to therapy, also showed positive results.

Study design: 301 was a 13-week, double-blind, placebo and naproxen- controlled trial, in patients with osteoarthritis of the knee. 918 eligible patients were randomized on a 1:1:1:1 basis at 120 clinical sites in the United States to receive: naproxcinod 375 mg bid, naproxcinod 750 mg bid, naproxen 500 mg bid or placebo bid. Eligible patients were at least 40 years old, with a clinical diagnosis of primary osteoarthritis of the knee of at least 3 months duration, confirmed by radiographs, and diagnosed according to the ACR guidelines (patients must have qualified as ACR global functional status I, II or III). There were no statistically significant differences among the four treatment groups for any baseline variables, including hypertension medical history (approximately half of enrolled patients had a medical history of hypertension at baseline).

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxide-donating technology to develop an internal portfolio of New Chemical Entities (NCEs) in the therapeutic areas of inflammatory and cardio-metabolic disease.

Resources are focused on the development of naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in 2008.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
2. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
3. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
4. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
5. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
6. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
7. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
8. NicOx Naproxcinod ABPM Data Presented at American Heart Association
9. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
10. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
11. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Asterias Biotherapeutics, Inc. (OTCBB: ... of regenerative medicine, announced today the appointments of Andrew ... newly expanded Board of Directors. With these additions, the ... of whom are independent. Andy Arno ... emerging growth companies. He is currently Managing Director of ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 19,030 ...
Breaking Medicine Technology:Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... , The US FDA announced on August 19, that ... Systems, model number DPB-125MICRO145 (Part number 7-10003), by Cardiovascular ... defective saline sheaths that could fracture during use and ...
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about ... top PRP therapy LA specialist has firmly stated that ... with practical well researched science and nothing to do ... new medical breakthrough technology which focuses on healing and ... therapy. , The Managing Director of one of the ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Teen substance abuse ... Toledo, OH. The rising numbers of young adults falling victim ... staggering. To help make a difference in the community, the ... valuable resource for teens seeking to overcome their chemical dependency. ... find the best youth rehab center to focus on achieving ...
(Date:8/22/2014)... 2014 The rising numbers of teenage ... Over the years, countless lives have been lost due to ... in the community a new helpline was established to provide ... Northeast Ohio who are seeking to overcome their chemical dependency ... at (300) 400-2616, parents and their teens can speak immediately ...
(Date:8/22/2014)... Lexington, North Carolina (PRWEB) August 22, 2014 ... United Church Homes and Services (UCHS ), recently ... frail and at risk seniors with limited resources in ... open floor plan, fully operational kitchen, individually controlled heating ... The HUD Section 202 supportive housing community, consists of ...
Breaking Medicine News(10 mins):Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2Health News:Troubled Teens in Akron, OH Can Receive Assistance from New Helpline for Addiction Recovery 2Health News:United Church Homes and Services Announce New Affordable Housing Community for Seniors 2
... Vall d,Hebron Hospital have diagnosed two patients affected with ... breathing due to irritating agents that are breathed in ... described two cases of patients with occupational vocal dysfunction. ... a closure in the vocal cords when inhaling. Under ...
... MINNEAPOLIS, Sept. 6 Two new issue briefs ... management,programs are evolving into employer partners to create ... ) "Corporate America Embraces New Culture ... of this emerging phenomenon:,a proactive vision for corporations ...
... NOT Vote for Merger; Says ,Shareholders Have Already ... at $5.60 per Share, NEW YORK, Sept. 6 Elliott ... (Nasdaq: BIVN ), today said the following letter has been ... Board of Directors Bioenvision, Inc. 345 Park Avenue, 41st ...
... Kris Carr is a photographer, director, producer and subject of ... Cancer." Carr is also the author of "Crazy Sexy Cancer Tips." ... and incurable cancer, but weeks later she ... treatment as her only option, Carr became determined to find ...
... Starting Drug Use with Painkillers Than Marijuana; Prescription ... Drug Abuse Remains a Concern, WASHINGTON, ... a five year low, according to the largest and,most comprehensive study of ... youth, nonmedical use of painkillers continues to be,an area of concern, with ...
... Sept. 6, 2007 CIGNA Group,Insurance today announced ... medical officer. Woolf will have responsibility for managing ... promote health and,wellness, absence management and productivity. ... clinical and business leaders,for CIGNA Group Insurance,s disability, ...
Cached Medicine News:Health News:Vocal cord dysfunction may be caused by work 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 2Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 4Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 5Health News:Author Kris Carr to Sign 'Crazy Sexy Cancer Tips' at Two Borders(R) Stores in California 2Health News:Youth Drug Use at a Five Year Low, New Survey Shows 2Health News:Youth Drug Use at a Five Year Low, New Survey Shows 3Health News:Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: